Access icon

Case Report March 14, 2024

Urinary Incontinence: A Rare Adverse Effect of Olanzapine

; ;

Prim Care Companion CNS Disord 2024;26(2):23cr03631

  1. Gómez JC, Sacristán JA, Hernández J, et al; Pharmacoepidemiologic Study of Olanzapine in Schizophrenia. The safety of olanzapine compared with other antipsychotic drugs: results of an observational prospective study in patients with schizophrenia (EFESO Study). J Clin Psychiatry. 2000;61(5):335–343. PubMed CrossRef
  2. Ganguli M, Ratcliff G, Chandra V, et al. A Hindi version of the MMSE: the development of a cognitive screening instrument for a largely illiterate rural elderly population in India. Int J Geriatr Psychiatry. 1995;10(5):367–377. CrossRef
  3. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239–245. PubMed CrossRef
  4. Harrison-Woolrych M, Skegg K, Ashton J, et al. Nocturnal enuresis in patients taking clozapine, risperidone, olanzapine and quetiapine: comparative cohort study. Br J Psychiatry. 2011;199(2):140–144. PubMed CrossRef
  5. Vernon LT, Fuller MA, Hattab H, et al. Olanzapine-induced urinary incontinence: treatment with ephedrine. J Clin Psychiatry. 2000;61(8):601–602. PubMed CrossRef
  6. Sagar R, Varghese ST, Balhara YP. Olanzapine-induced double incontinence. Indian J Med Sci. 2005;59(4):163–164. PubMed CrossRef
  7. Dada MU, Oluwole LO, Adegun PT, et al. Olanzapine as a cause of urinary incontinence: a case report. Iran J Psychiatry. 2012;7(3):146–148. PubMed
  8. Tuman TC, Cakir U, Yildirim O. Olanzapine-induced urinary incontinence. Anadolu Psikiyatri Derg. 2016;17:15.
  9. Arasteh A, Mostafavi S, Zununi Vahed S, et al. An association between incontinence and antipsychotic drugs: a systematic review. Biomed Pharmacother. 2021;142:112027. PubMed CrossRef